Zhang S - Search Results

1

Myeloid-Mas Signaling Modulates Pathogenic Crosstalk among MYC⁺CD63⁺ Endothelial Cells, MMP12⁺ Macrophages, and Monocytes in Acetaminophen-Induced Liver Injury.

Chen S, Lu Z, Zhao Y, Xia L, Liu C, Zuo S, Jin M, Jia H, Li S, Zhang S, Yang B, Wang Z, Li J, Wang F, Yang C. Chen S, et al. Among authors: zhang s. Adv Sci (Weinh). 2024 Apr;11(16):e2306066. doi: 10.1002/advs.202306066. Epub 2024 Feb 13. Adv Sci (Weinh). 2024. PMID: 38350725 Free PMC article.

2

Nomogram for predicting the risk of gastroesophageal varices after primary endoscopic prophylaxis for variceal hemorrhage in patients with cirrhosis.

Zhang S, Song W, Chang Y, Wang S, Yang L, Yang C. Zhang S, et al. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e131-e139. doi: 10.1097/MEG.0000000000001983. Eur J Gastroenterol Hepatol. 2021. PMID: 33177379

3

A non-invasive model based on the virtual portal pressure gradient to predict the first variceal hemorrhage in cirrhotic patients.

Zhang S, Song W, Yang B, Jia H, Chen S, Li J, Yang C. Zhang S, et al. Hepatol Int. 2022 Aug;16(4):926-935. doi: 10.1007/s12072-022-10344-5. Epub 2022 May 18. Hepatol Int. 2022. PMID: 35585289

4

A Dynamic Nomogram Predicting Portal Vein Thrombosis in Cirrhotic Patients During Primary Prophylaxis for Variceal Hemorrhage.

Zhang S, Ji B, Zhong X, Zhong L, Yang L, Yang C. Zhang S, et al. Front Med (Lausanne). 2022 Jun 3;9:887995. doi: 10.3389/fmed.2022.887995. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35721053 Free PMC article.

5

Hepatocyte-specific Mas activation enhances lipophagy and fatty acid oxidation to protect against acetaminophen-induced hepatotoxicity in mice.

Chen S, Lu Z, Jia H, Yang B, Liu C, Yang Y, Zhang S, Wang Z, Yang L, Li S, Li J, Yang C. Chen S, et al. Among authors: zhang s. J Hepatol. 2023 Mar;78(3):543-557. doi: 10.1016/j.jhep.2022.10.028. Epub 2022 Nov 9. J Hepatol. 2023. PMID: 36368597 Free article.

6

Prognostic value of virtual portal pressure gradient response in compensated cirrhotic patients treated with carvedilol.

Zhang S, Cai L, Zhong H, Yang B, Song W, Jia H, Chen S, Zhu F, Li J, Yang C. Zhang S, et al. Hepatol Res. 2024 Jan;54(1):78-90. doi: 10.1111/hepr.13963. Epub 2023 Sep 20. Hepatol Res. 2024. PMID: 37668257

7

FBXL5 promotes lipid accumulation in alcoholic fatty liver disease by promoting the ubiquitination and degradation of TFEB.

Zhang S, Ji B, Li J, Ji W, Yang C, Yang L. Zhang S, et al. Cell Signal. 2023 Dec;112:110905. doi: 10.1016/j.cellsig.2023.110905. Epub 2023 Sep 23. Cell Signal. 2023. PMID: 37743009

8

Predicting the risk of variceal rehemorrhage in cirrhotic patients with portal vein thrombosis: A two-center retrospective study.

Zhang S, Zhong X, Zhong H, Zhong L, Li J, Zhu FS, Xia L, Yang CQ. Zhang S, et al. J Dig Dis. 2023 Nov;24(11):619-629. doi: 10.1111/1751-2980.13239. Epub 2023 Dec 6. J Dig Dis. 2023. PMID: 37950606

9

Development and external validation of prognostic scoring models for portal vein thrombosis: a multicenter retrospective study.

Zhong X, Li S, Hu J, Lu J, Wang W, Hu M, Sun Q, Zhang S, Yang X, Yang C, Zhong L. Zhong X, et al. Among authors: zhang s. Thromb J. 2023 Jan 23;21(1):9. doi: 10.1186/s12959-023-00455-w. Thromb J. 2023. PMID: 36691024 Free PMC article.

10

Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11.

Zhou B, Luo Y, Bi H, Zhang N, Ma M, Dong Z, Ji N, Zhang S, Wang X, Liu Y, Guo X, Wei W, Xie C, Wu L, Wan X, Zheng MH, Zhao B, Li Y, Hu C, Lu Y. Zhou B, et al. Among authors: zhang n, zhang s. Cell Metab. 2024 Oct 1;36(10):2228-2244.e7. doi: 10.1016/j.cmet.2024.07.014. Epub 2024 Aug 14. Cell Metab. 2024. PMID: 39146936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83,541 results

Search Page

Filters